Meghmani Organics: Q4 Slump Masks Strong 9-Month Turnaround

CHEMICALS
Whalesbook Logo
AuthorAarav Shah|Published at:
Meghmani Organics: Q4 Slump Masks Strong 9-Month Turnaround
Overview

Meghmani Organics reported mixed Q4 FY26 results. Standalone revenue and profit declined YoY, but the nine-month period saw substantial YoY growth in PBT and net profit. Consolidated Q4 revenue fell, with a net loss reported, though it improved year-on-year. However, the consolidated nine-month figures show a dramatic turnaround with positive PBT and net profit. The agrochemical segment drives profits while pigments continue to report losses. No specific forward guidance was issued.

📉 The Financial Deep Dive

Meghmani Organics Limited announced its un-audited financial results for the quarter and nine months ended December 31, 2025 (Q4 FY26 & 9M FY26), revealing a significant divergence in performance.

The Numbers:
On a standalone basis, revenue from operations for Q4 FY26 declined 13.1% YoY to ₹484.94 Cr. Profit Before Tax (PBT) fell 27.9% YoY to ₹303.39 Cr, and Net Profit decreased 26.1% YoY to ₹222.98 Cr. However, for the nine-month period (9M FY26), standalone revenue grew 8.9% YoY to ₹1635.20 Cr, with PBT surging 240% YoY to ₹1398.43 Cr and Net Profit rising 225% YoY to ₹1057.27 Cr.

Consolidated revenue from operations for Q4 FY26 was ₹508.74 Cr, down 10.5% YoY. Consolidated PBT was ₹45.08 Cr, a 39.2% decline YoY. The company reported a consolidated net loss of ₹35.28 Cr for Q4 FY26, an improvement from a net loss of ₹43.92 Cr in the prior year. For 9M FY26, consolidated revenue grew 11.4% YoY to ₹1699.61 Cr. Crucially, consolidated PBT turned positive at ₹548.96 Cr from a loss of ₹210.79 Cr in 9M FY25, and Net Profit was ₹207.08 Cr, a significant turnaround from a net loss of ₹304.18 Cr.

The Quality:
Standalone PBT margins for Q4 FY26 were 6.07% (down from 7.42% YoY), but improved to 8.25% for 9M FY26 (from 2.70% in 9M FY25). Consolidated PBT margins were weak in Q4 FY26 at 0.86% (down from 1.28% YoY) but improved substantially on a 9M basis to 3.12% (from a negative margin). The pigment segment continued to report losses on a consolidated basis, while the agrochemical segment remained the primary profit driver. Standalone basic EPS for Q4 FY26 was ₹1.19 (down from ₹4.16 YoY), but for 9M FY26 it was ₹12.80 (up from ₹3.21). Consolidated Basic EPS for Q4 FY26 was ₹(0.14) (improved from ₹(0.17)), and for 9M FY26 it was ₹0.81 (up from ₹(1.20)).

🚩 Risks & Outlook

Specific Risks: The pigment segment's ongoing losses are a key concern. The YoY decline in Q4 performance could indicate softening demand or pricing pressures. The impact of new Labour Codes is under evaluation, which may lead to unforeseen cost implications. Past fire incidents and related insurance claims/losses have been accounted for, but any recurrence poses a risk.

The Forward View: Investors should monitor the pigment segment's performance closely. The ability of Meghmani Organics to sustain the nine-month turnaround into the next fiscal year, particularly on a consolidated basis, will be critical. The market's reaction to the Q4 YoY decline versus the robust nine-month performance needs to be observed. The company provided no specific forward-looking guidance, making the outlook unstated.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.